Pharmaceutical News

RSS

Researchers reveal why anti-androgen therapy may fail in men with prostate cancer

Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.

16 Jun 2011

Geisinger uses mandatory approach to improve healthcare worker influenza vaccination rates

Geisinger Health System vaccinated more than 92% of all employees against influenza this season, with a modification of a mandatory program. On average, fewer than half of all healthcare workers receive flu vaccinations.

16 Jun 2011

'Cell membrane capsules' made from real living cells improve functional drug delivery

The quest for better ways of encapsulating medicine so that it can reach diseased parts of the body has led scientists to harness - for the first time - living human cells to produce natural capsules with channels for releasing drugs and diagnostic agents.

16 Jun 2011

Antibiotics overprescribed for in home-care patients

A study of Canadian home-care patients suggests doctors may be overprescribing antibiotics for patients receiving ongoing medical care at home.

16 Jun 2011

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody product for Age-related Macular Degeneration (AMD) and other eye disorders.

16 Jun 2011

Liraglutide medication can help treat type 1 diabetes

Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.

16 Jun 2011

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

Some lung-cancer patients at UT Southwestern Medical Center are responding well to potential new drug therapies targeting genetic mutations. Their participation in a national study is helping to forge new avenues to attack the disease.

16 Jun 2011

ViroPharma receives European Centralized Marketing Authorization for Cinryze for treatment of HAE

ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.

16 Jun 2011

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

The U.S. Food and Drug Administration today approved Nulojix to prevent acute rejection in adult patients who have had a kidney transplant. The drug is approved for use with other immunosuppressants -- specifically basiliximab, mycophenolate mofetil, and corticosteroids.

16 Jun 2011

Cholesterol-lowering statins reduce rate of mortality and cardiovascular events

Over the long term, treatment with cholesterol-lowering statins reduces the rate of mortality and cardiovascular events such as heart attack, for people with and without heart disease. Still, it is unclear whether these drugs take effect rapidly when the risk of these dire events is highest.

15 Jun 2011

Cardinal Health renews pharmaceutical distribution agreement with Prime Therapeutics

Cardinal Health today announced that it has signed a renewed, three-year agreement with Prime Therapeutics, one of the nation's leading pharmacy benefit managers, to continue to serve as its primary pharmaceutical supply chain partner for its mail-service pharmacy, PrimeMail®.

15 Jun 2011

Galectin strengthens cancer drug patent portfolio in Europe

Galectin Therapeutics Inc. today announced that the European Patent Office has granted the Company a new patent, No. 02731178.6, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer".

15 Jun 2011

FDA issues final rulemaking on testing and labeling of sunscreen products

"FDA's recognition today of the important role sunscreens play in protecting the public not only from sunburn but also from skin cancer and premature aging due to the sun is a very significant victory for public health. The role of UV rays in causing skin damage and the role of sunscreens in protecting against this sun damage are widely acknowledged within the medical and scientific communities, and we're very pleased the agency has taken this critical step.

15 Jun 2011

Pharmaceutical News

Researchers reveal why anti-androgen therapy may fail in men with prostate cancer

Geisinger uses mandatory approach to improve healthcare worker influenza vaccination rates

'Cell membrane capsules' made from real living cells improve functional drug delivery

Antibiotics overprescribed for in home-care patients

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

Liraglutide medication can help treat type 1 diabetes

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

ViroPharma receives European Centralized Marketing Authorization for Cinryze for treatment of HAE

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

Cholesterol-lowering statins reduce rate of mortality and cardiovascular events

Cardinal Health renews pharmaceutical distribution agreement with Prime Therapeutics

Galectin strengthens cancer drug patent portfolio in Europe

FDA issues final rulemaking on testing and labeling of sunscreen products

Leukothera effectively treats psoriasis in humanized mouse xenograft transplantation model

GlycoVaxyn's Second Annual Science Day to highlight challenges of vaccine industry

Botox injections can reduce wrinkles with half as many sessions after 20 months

Editorial, opinion pieces respond to GAVI pledging conference

APP announces $38 million expansion of New York manufacturing facility

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

Meningitis vaccine showing success in West Africa

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News